2013
DOI: 10.1089/sur.2012.091
|View full text |Cite
|
Sign up to set email alerts
|

Vancomycin versus Linezolid in the Treatment of Methicillin-Resistant Staphylococcus aureus Meningitis

Abstract: Analysis of the findings in the limited cohorts in our study suggests that linezolid is superior to vancomycin for treating MRSA meningitis, especially in cases in which there is a high MIC (2 mg/L) for vancomycin. A clinical study involving larger cohorts may increase the evidence available in relation to this question.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
17
0
1

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(21 citation statements)
references
References 11 publications
3
17
0
1
Order By: Relevance
“…We have found that all MRSA isolates tested in the present study were fully sensitive to vancomycin so it may be used as the drug of choice for treating multidrug-resistant MRSA infections. Similar findings were reported by various previous studies (Singh et al 2013 ; Sipahi et al 2013 ; Bhatt et al 2014 ; Chelliah et al 2014 ). In addition, all isolates were sensitive to linezolid which is in line with other studies (Sipahi et al 2013 ; Vijayamohan and Nair 2014 ).…”
Section: Discussionsupporting
confidence: 91%
“…We have found that all MRSA isolates tested in the present study were fully sensitive to vancomycin so it may be used as the drug of choice for treating multidrug-resistant MRSA infections. Similar findings were reported by various previous studies (Singh et al 2013 ; Sipahi et al 2013 ; Bhatt et al 2014 ; Chelliah et al 2014 ). In addition, all isolates were sensitive to linezolid which is in line with other studies (Sipahi et al 2013 ; Vijayamohan and Nair 2014 ).…”
Section: Discussionsupporting
confidence: 91%
“…It remains off licence for treating infections of the central nervous system (CNS) 15. Existing case series have shown promising outcomes for SEAs and CNS infections treated with linezolid,7 16 including those caused by methicillin-resistant S. aureus ,17 the incidence of which (SEAs) has been reported to be increasing 2. Resolution of meningitis in a 67-year-old patient caused by GBS has been reported after treatment with linezolid in conjunction with meropenem, where improvement occurred after linezolid was given 18.…”
Section: Discussionmentioning
confidence: 99%
“…Nosocomial meningitis was defined as bacterial infection not present when the patient was admitted to the hospital or clinical evidence of infection within a short period of time after discharge from the hospital where the patient had received an invasive procedure. Patients developing meningitis after neurosurgical procedures were defined as having postneurosurgical infection [11,20]. Accordingly, all cases had nosocomial post neurosurgical meningitis.…”
Section: Accepted Manuscript 2 Materials and Methodsmentioning
confidence: 99%
“…In spite of developments in neurosurgery, antimicrobial agents, medicine and intensive care, meningitis, as well as nosocomial or healthcare-associated meningitis (HCAM), are still associated with significant mortality and morbidity[1][2][3][4][5][6][7][8][9][10][11]. Multidrug-resistant (MDR) as well as carbapenem-resistant Acinetobacter baumannii (CRAB)…”
mentioning
confidence: 99%